Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22264Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mikhailidis, D. P. | en |
| dc.contributor.author | Khan, M. A. | en |
| dc.contributor.author | Milionis, H. J. | en |
| dc.contributor.author | Morgan, R. J. | en |
| dc.date.accessioned | 2015-11-24T19:23:13Z | - |
| dc.date.available | 2015-11-24T19:23:13Z | - |
| dc.identifier.issn | 0300-7995 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22264 | - |
| dc.rights | Default Licence | - |
| dc.subject | Antihypertensive Agents/*adverse effects/therapeutic use | en |
| dc.subject | Diabetes Complications | en |
| dc.subject | Doxazosin/pharmacology/therapeutic use | en |
| dc.subject | Erectile Dysfunction/chemically induced/complications/*prevention & control | en |
| dc.subject | Humans | en |
| dc.subject | Hypertension/complications/*drug therapy | en |
| dc.subject | Male | en |
| dc.subject | Phosphodiesterase Inhibitors/therapeutic use | en |
| dc.subject | Piperazines/therapeutic use | en |
| dc.subject | Purines | en |
| dc.subject | Sulfones | en |
| dc.title | The treatment of hypertension in patients with erectile dysfunction | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11329820 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2000 | - |
| heal.abstract | Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease and ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker, doxazosin, has not been associated with an increased incidence of ED as a side effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED. | en |
| heal.journalName | Current Medical Research and Opinion | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
